<DOC>
	<DOCNO>NCT02209675</DOCNO>
	<brief_summary>Assessment role tissue C4d complement fragment liver biopsy new marker differentiate acute rejection Hepatitis C ( HCV ) recurrence recipient post live donor liver transplantation ( LDLT ) .As condition require different treatment</brief_summary>
	<brief_title>Role Tissue C4d Differentiation Between Acut e Rejection HCV Recurrence After Liver Transplantation</brief_title>
	<detailed_description>Role tissue c4d assessment immunohistchemistry liver biopsy differentiation recurrent hepatitis c rejection liver transplantation.pathological examination may sometimes confuse rejection recurrent hepatitis C</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Patients transplant HCV related disease present elevate liver enzyme and/or hyperbilirubinemia normal Abdominal Doppler ultrasound Magnetic resonance cholangiography ( MRCP ) . Evidence cause elevate liver enzyme and/or hyperbilirubinemia abnormal Abdominal Doppler ultrasound and/or Magnetic resonance cholangiography MRCP finding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>hepatitis C recurrence</keyword>
	<keyword>Rejection</keyword>
	<keyword>Liver Transplantation</keyword>
	<keyword>Liver biopsy</keyword>
</DOC>